Apixaban versus aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischaemic attack: subgroup analysis of the ARTESiA randomised controlled trial

https://www.thelancet.com/collections/neurology?dgcid=hubspot_email_infocusalerts-neurology_feature&parent=001585&startPage=&ContentItemType=fla&utm_campaign=infocusalerts-neurology&utm_medium=email&_hsenc=p2ANqtz-84_fwuNvty3Sry-3b5wKrjkUT6CCUrKNZaglOkpHwNPEwh3NvkNQtGZDom44pIwsL55XpRxSW1bfuAKFVpCtCRV9luKg&_hsmi=344019965&utm_content=343601522&utm_source=hs_email